Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)

Clinical trial NCT05724004 · RECRUITING

Trial details

NCT number: NCT05724004
Sponsor: Karolinska University Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Radiotherapy Side Effect Non-small Cell Lung Cancer ALK Gene Mutation

Start date: 2023-10-05
Primary completion: 2024-06-20
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.